Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Enlivex Ltd. (ENLV) vs Kiora Pharmaceuticals, Inc. (KPRX)

Enlivex Ltd. and Kiora Pharmaceuticals, Inc. are both Biotechnology companies. Enlivex Ltd. and Kiora Pharmaceuticals, Inc. are of similar size ($11.8M and $11.3M). Kiora Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Enlivex Ltd. trades at 0.0×. Across the 12 metrics below, Enlivex Ltd. leads on 7 and Kiora Pharmaceuticals, Inc. on 5.

Valuation

Metric ENLV KPRX Biotechnology median
P/E 0.00 n/m 7.88
P/S n/m 0.87 11.47
P/B 0.00 0.96 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 118.16 0.05 0.74
EV/Sales n/m (0.03) 10.73
Earnings yield 67,549.40% (94.06%) (28.84%)
Free cash flow yield (573.24%) (53.02%) (23.03%)

Profitability

Metric ENLV KPRX Biotechnology median
Gross margin 0.00% 85.06% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 126.17% (56.36%) (57.72%)
Return on assets 104.94% (39.43%) (49.22%)
Return on invested capital (4.78%) (44,053.91%) 0.00%

Growth

Metric ENLV KPRX Biotechnology median
Revenue growth (TTM) — 983.73% 5.64%
EPS growth (last fiscal year) 3,590.26% (403.45%) —
Revenue growth, 5-year CAGR — 88.72% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENLV KPRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 193.24 8.97 4.73
Net debt to EBITDA 118.29 1.33 0.96

Dividend

Metric ENLV KPRX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ENLV KPRX Biotechnology median
Market cap 11.33m 11.81m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack